Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

AMLXAMLX

Showing 8 of 12 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in AMYLYX PHARMACEUTICALS INC

Current Value

$12.9M

Current Shares

721,002

Total Value Change

+$10.1M

Total Shares Change

-159,743

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
721,002
-17.0%
$12.9M0.0%$17.96
0
2026-Q1
Decreased
868,325
-13.5%
$12.1M0.0%$14.11
0
2025-Q4
Decreased
1M
-9.3%
$12.1M0.0%$12.00
0
2025-Q3
Decreased
1.1M
-4.1%
$15M0.0%$14.90
0
2025-Q2
Decreased
1.2M
-3.8%
$7.4M0.0%$6.33
0
2025-Q1
Decreased
1.2M
-5.0%
$4.2M0.0%$3.66
0
2024-Q4
Increased
1.3M
+43.4%
$4.8M0.0%$3.84
36
2024-Q3
Increased
880,745
+41.6%
$2.9M0.0%$3.08
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used